Millic acid-producing pichia guilliermondii recombinant strain as well as construction method and application thereof

By constructing the recombinant bacteria of Pichia citrus, expressing the malic acid synthesis pathway gene, the safety and cost problems in existing malic acid production were solved, and efficient and safe L-malic acid production was achieved, with significantly improved output and Reduced production costs.

CN119040164APending Publication Date: 2024-11-29CHANGMAO BIOCHEMICAL ENG CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411387215.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-30
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing chemical synthesis process of malic acid has safety and sustainability problems, and mycotoxins may be produced during microbial fermentation, and the fermentation cycle is long and costly, making it difficult to efficiently produce purified L-malic acid.

Method used

A recombinant bacteria of Pichia schia ciensis was constructed, and the malate transporter gene Spmae of Rhizolid oryzae was achieved by expressing the pyruvate carboxylase gene Ropyc of Rhizolid oryzae, the malate transporter gene Spmae of Schizolidopsis yeast Efficient production of L-malic acid without adding neutralizing agents, reducing production costs using methanol and inferior carbon sources.

Benefits of technology

The production of L-malic acid was achieved efficiently, with a 90.76% increase in yield and a 90.76% increase in malic acid yield under low pH conditions, reducing the distance between the substrate and the product, strengthening the protein function, and reducing production costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040164A_ABST
    Figure CN119040164A_ABST
Patent Text Reader

Abstract

The invention relates to a pichia guilliermondii recombinant strain for producing malic acid as well as a construction method and application of the pichia guilliermondii recombinant strain. The recombinant strain is obtained by expressing a pyruvate carboxylase gene Ropyc derived from rhizopus oryzae, a malate dehydrogenase gene Romdh derived from rhizopus oryzae and / or a malic acid transporter gene Spmae derived from schizosaccharomyces pombe in host bacteria. Wherein the host bacterium is a pichia guilliermondii gene modified strain gsh-slc-E-EA20, and the host bacterium is a pichia guilliermondii gene modified strain. According to the recombinant strain constructed by the invention, the pichia guilliermondii is used as a host strain to produce malic acid, and the recombinant strain has relatively strong stress resistance, relatively high product synthesis rate and shortened fermentation period.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the fields of genetic engineering and biotechnology, and in particular to a recombinant strain of Pichia guilliermondii producing malic acid, a construction method and application thereof. Background Art

[0002] Malic acid, also known as 2-hydroxysuccinic acid, has two stereoisomers due to an asymmetric carbon atom in the molecule. In nature, it exists in three forms, namely D-malic acid, L-malic acid and its mixture DL-malic acid. It is a white crystal or crystalline powder, has strong hygroscopicity, is easily soluble in water and ethanol, and has a special pleasant sour taste. Malic acid plays an important role in human metabolism and can effectively improve athletic ability and resist fatigue. At the same time, L-malic acid has strong decontamination ability and can be added to daily chemical products such as toothpaste and facial cleanser. Therefore, L-malic acid is widely used in food, medicine, health care products and chemical industries, with an annual output of about 40,000 tons, and the potential demand in the world market reaches 60,000 tons per year.

[0003] Malic acid is mainly used in the food and pharmaceutical industries. At present, malic acid is mainly produced by chemical synthesis processes. However, since chemical processes may produce toxic and non-degradable / recyclable byproducts, people are increasingly concerned about the safety and sustainability of chemical processes. In addition, only L-malate can be used in food and medicine, but the chemical synthesis process produces a mixture of D- and L-malate, which is not suitable for food and medicine. In contrast, since microorganisms produce L-malic acid instead of D-malic acid, fermentation-based production processes may be more attractive. However, the main wild strains of microbial fermentation are molds, but their presence may cause mycotoxins in the fermentation products, the fermentation cycle is long, and the mycelium and fungus balls are uncontrollable during fermentation. At the same time, a large amount of neutralizers need to be added during mold fermentation, which increases the production cost and the difficulty of separating products downstream. Therefore, the development of safe and acid-resistant engineered yeast is the key to achieving efficient synthesis of L-malic acid. In addition, Pichia guilliermong can naturally use methanol as a carbon source, which reduces the production cost for the biosynthesis of malic acid and can achieve high-value conversion of low-quality biomass resources. Summary of the invention

[0004] The first object of the present invention is to provide a recombinant strain of Pichia guilliermondii that produces malic acid.

[0005] In order to achieve the above technical objectives, the present invention adopts the following scheme: A recombinant strain of Pichia guilliermondii producing malic acid, wherein the recombinant strain expresses a pyruvate carboxylase gene derived from Rhizopus oryzae in a host bacterium Ropyc , malate dehydrogenase gene Romdhand / or a malate transporter gene from Schizosaccharomyces pombe Spmae get; Wherein, the host bacteria is a genetically modified strain of Pichia guilliermongo gsh-slc-E-EA20 .

[0006] As a preferred embodiment, the Ropyc Gene, Romdh Genes are fused and expressed by inserting linkers.

[0007] As a preferred embodiment, the amino acid sequence of the linker is GGGGGGGG, GGGEKGGG, GGGSGGGS or GGGGSGGPGS; preferably GGGSGGGS.

[0008] As a preferred embodiment, the Ropyc , Romdh and Spmae The nucleotide sequences are shown in SEQ ID NOs: 1-3, respectively.

[0009] The second object of the present invention is to provide a method for constructing the above-mentioned recombinant bacteria, comprising: Build Ropyc , Romdh and / or Spmae The co-expression plasmid is linearized and then introduced into a host bacterium through a yeast transformation kit to obtain the recombinant bacterium.

[0010] As a preferred embodiment, for expressing Ropyc , Romdh and Spmae The vector plasmid of the gene is 113-GPD-TEF plasmid.

[0011] The third object of the present invention is to provide the use of the above-mentioned recombinant bacteria in the fermentation production of malic acid.

[0012] As a preferred embodiment, the recombinant bacteria is subjected to seed culture and fermentation culture to synthesize malic acid.

[0013] As a preferred embodiment, the fermentation temperature of the recombinant bacteria is 18-37°C; preferably 30-33°C.

[0014] As a preferred embodiment, the culture medium for the fermentation culture of the recombinant bacteria does not contain a neutralizer.

[0015] The present invention has the following beneficial effects: (1) The present invention utilizes Pichia guilliermondii to produce malic acid. Compared with Saccharomyces cerevisiae, Pichia guilliermondii has a higher secretion capacity for proteins with low glycosylation modification. In addition, Pichia guilliermondii is also a relatively rare yeast that can use alkanes as the only carbon source and energy source, and can also use methanol as a carbon source, making it possible to use methanol or other low-quality carbon sources to replace glucose to achieve malic acid production in the future, thereby realizing the high-value conversion of products using low-quality biomass resources.

[0016] (2) The present invention utilizes a strain of Pichia guilliermong with good stress resistance gsh-slc-E-EA20 Rhizopus oryzae Ropyc and Romdh and the source of Schizosaccharomyces pombe Spmae The recombinant strain R2-S obtained by the gene successfully synthesized 6.42 g / L of L-malic acid. In addition, the present application introduced different linkers between the Ropyc and Romdh genes: GGGGGGGG, EKGGGEK, GGGEKGGG, GGGSGGGS and GGGGSGGPGS for fusion protein expression, among which the L-malic acid yield of the introduced Linker-GGGSGGGS was 10.74 g / L, an increase of 90.76%.

[0017] (3) The recombinant bacteria constructed by the present invention can achieve efficient production of malic acid without adding any pH regulator to the fermentation system. In addition, the present invention is the first to introduce a linker into the malic acid-producing Pichia guilliermongo to fusion express the key gene for malic acid synthesis, which effectively reduces the distance between the substrate and the product, facilitates the rapid conversion of the substrate, realizes the enhancement of protein function, and further increases the yield of malic acid at low pH, providing a reference for other microbial fermentations. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 For the recombinant plasmid 113-GPD-TEF- hph - Ropyc , Ropyc The promoter is pTEFin and the terminator is tCYC1.

[0019] Figure 2 For the recombinant plasmid 113-GPD-TEF- hph - Ropyc - Romdh , Romdh The promoter is pGPD and the terminator is tXRP2.

[0020] Figure 3 For the recombinant plasmid 113-GPD-TEF- hph -Ropyc- Romdh -Spmae , Spmae The promoter is pTEFin and the terminator is tCYC1.

[0021] Figure 4 For the recombinant plasmid 113-GPD-TEF- hph - Ropyc -Linker4- Romdh .

[0022] Figure 5 For the recombinant plasmid 113-GPD-TEF- hph - Ropyc -Linker4- Romdh - Spmae .

[0023] Figure 6 The yield of L-malic acid produced by the starting strain and different recombinant strains.

[0024] Figure 7 Recombinant bacteria R-Linker 4 -R-S L-malic acid production at different fermentation temperatures.

[0025] Figure 8 Recombinant bacteria R-Linker 4 -R-S L-malic acid production in a fed-batch fermenter. DETAILED DESCRIPTION

[0026] The present invention will be further described below in conjunction with specific embodiments. Unless otherwise specified, the experimental methods used in the following examples are conventional methods.

[0027] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0028] The starting strain used in the example is a genetically modified strain constructed using Pichia guilliermongo EA20 (accession number CCTCC NO: M2022053) as the host strain. gsh-slc-E-EA20 strain, the genetically modified strain has been disclosed in the applicant's prior application CN116836826A.

[0029] The vector plasmid 113-GPD-TEF-hph in the embodiment has been disclosed in the applicant's previous article Jing Y, Wang J, Gao H, Jiang Y, Jiang W, Jiang M, Xin F, Zhang W. Enhanced β-caroteneproduction in Yarrowia lipolytica through the metabolic and fermentation engineering. J Ind Microbiol Biotechnol. 2023 Feb 17;50(1):kuad009. doi:10.1093 / jimb / kuad009. PMID: 37055369; PMCID: PMC10124129.

[0030] Example 1 This example illustrates the starting strain gsh-slc-E-EA20 The construction method of , which can be specifically referred to the applicant's prior application CN116836826A, mainly includes the following steps: (1) Construction of recombinant plasmids containing stress-resistant elements The genome of Pichia guilliermongi EA20 was extracted using a yeast genomic DNA extraction kit. The genome was used as a template and primers were used to amplify four stress-resistant elements with pTEF promoter and tCYC1 terminator homology arms at both ends. strap , ampk , gdh , tcyc , will be marked with a filter hph Plasmid 113-GPD-TEF- hph Linearize with restriction endonuclease Swal; connect and integrate the linearized vector plasmid with the target gene with corresponding promoter and terminator homology arms at both ends through a one-step cloning transformation kit to obtain a new plasmid, and transform it into Escherichia coli competent cells. DH5α The recombinant plasmid was named 113-GPD-TEF- hph - ampk 、113-GPD-TEF- hph - strap 、113-GPD-TEF- hph - tcyc and 113-GPD-TEF- hph - gdh .

[0031] (2) Construction of engineered strain E-EA20 First ampk , ampk , strap The three genes were co-expressed. gdh Express alone.

[0032] a. Construction of recombinant plasmids co-expressing stress resistance elements Plasmid 113-GPD-TEF- hph - tcyc As a template, PCR amplification was performed using primers to obtain the target fragment ampk ; Use restriction endonuclease Pme I to digest plasmid 113-GPD-TEF- hph - tcyc Linearize it; use a one-step cloning transformation kit to transform the linear plasmid vector 113-GPD-TEF- hph - tcyc With the target fragment ampk The new plasmid was obtained by ligation and integration and then transformed into competent E. coli DH5α The plasmid was then plated on an LB screening plate containing ampicillin resistance (100 mg / L). Positive clones were selected for PCR verification and sequencing verification to obtain plasmid 113-GPD-TEF- hph - tcyc - ampk The recombinant plasmid 113-GPD-TEF- hph - tcyc - ampk - strap .

[0033] b. Insert the co-expression plasmid 113-GPD-TEF- hph - tcyc - ampk - strap and recombinant plasmid 113-GPD-TEF- hph - gdh The linearized DNA fragment was digested with restriction endonuclease Not I, and the linearized DNA fragment was integrated into the EA20 yeast genome using yeast transformation method.

[0034] The co-expression plasmid 113-GPD-TEF- hph - tcyc - ampk - strapAfter the linear DNA fragment was integrated into the EA20 yeast genome, it was spread on a 0.2 g / L HPH resistance screening plate and cultured for 2-3 days. The positive clones were selected for PCR verification. The correct clones were inoculated into YPD tubes for overnight culture and the genome was extracted for sequencing verification. The successfully constructed recombinant engineering strain EA20- tcyc - ampk - strap . The above constructed plasmid 113- hph-gdh The linear DNA fragment was then integrated into the engineered strain EA20- tcyc - ampk - strap The genome was spread on a screening plate with a higher hygromycin B resistance concentration (0.4 g / L HPH) and cultured for 2 to 3 days. The positive clone points were selected for PCR verification, and the correct points were inoculated into YPD test tubes for overnight culture. The genome was extracted for sequencing verification, and finally the successfully constructed engineered strain E-EA20 was obtained.

[0035] (3) Construction of recombinant plasmids containing exogenous stress resistance elements The genomes of Pichia guilliermongi (MG) and Yarrowia lipolytica (YL) were extracted using a yeast genomic DNA extraction kit. The genomes were used as templates and two pairs of primers were used to gsh - YL F / R, slc - MG F / R amplified two target genes with pGPD promoter and txpr2 terminator homology arms at both ends. gsh - YL , gslc - MG , the above constructed hph Plasmid 113- hph Linearize with restriction endonuclease Sma I; connect and integrate the linearized vector plasmid with the target gene with corresponding promoter and terminator homology arms at both ends through a one-step cloning transformation kit to obtain a new plasmid, and transform it into Escherichia coli competent cells. DH5α The clones were plated on LB screening plates with ampicillin resistance (100 mg / L), and positive clones were selected for PCR verification and further sequencing verification. The recombinant plasmids with the target gene were named 113-GPD-TEF- hph - gsh -YL and 113-GPD-TEF - hph - slc -MG.

[0036] (4) Construction of recombinant plasmids co-expressing exogenous stress resistance elements Plasmid 113-GPD-TEF- hph - slc - MG As template, using primers slc - MG F / R PCR amplification to obtain the target fragment slc - MG ; Use restriction endonuclease Pme I to digest plasmid 113-GPD-TEF- hph - gsh - KM Linearize it; use a one-step cloning transformation kit to transform the linear plasmid vector 113-GPD-TEF- hph - gsh - KM With the target fragment slc - MG The new plasmid was obtained by ligation and integration and then transformed into competent E. coli DH5α The cells were plated on LB screening plates with ampicillin resistance (100 mg / L), and positive clones were selected for PCR verification and sequencing verification. hph - gsh - KM For carrier , Recombination with target fragment slc - MG The recombinant plasmid was named 113-GPD-TEF- hph - gsh - slc .

[0037] (5) Engineered strains gsh - slc -E-EA20 build: The plasmid 113-GPD-TEF- hph - gsh - slc The restriction endonuclease Not I was used for linearization to obtain the linear target fragment. The 113-GPD-TEF- hph - gsh - slc The linear DNA fragment was integrated into the genome of the engineering strain E-EA20, coated on a resistance screening plate with a higher concentration of hygromycin B (0.6g / L HPH), cultured for 2-3 days, and the positive clone points were selected for PCR verification. The verified points were inoculated into YPD test tubes for overnight culture, and the genome was extracted for sequencing verification. The final recombinant engineering strain was successfully constructed. gsh - slc-E-EA20.

[0038] Example 2 Amplification of genetic elements and preparation of target genes 1. Preparation of target gene According to the pyruvate carboxylase gene from Rhizopus oryzae provided by NCBI Ropyc Nucleotide sequence of malate dehydrogenase gene Romdh The nucleotide sequence of the malate transporter gene from Schizosaccharomyces pombe Spmae The nucleotide sequence of the gene was codon-optimized and then commissioned to GenScript Biotech Co., Ltd. for synthesis. Ropyc , Romdh , Spmae The gene sequences are shown as SEQ ID No: 1, SEQ ID No: 2 and SEQ ID No: 3 respectively.

[0039] The PCR reaction conditions were:

[0040] (ii) Recombinant plasmid 113-GPD-TEF- hph - Ropyc 、113-GPD-TEF- hph - Ropyc - Romdh and 113-GPD-TEF- hph - Ropyc - Romdh - Spmae 's construction.

[0041] 1. Recombinant plasmid 113-GPD-TEF- hph - Ropyc Construction Recombinant plasmid 113-GPD-TEF- hph - Ropyc Based on 113-GPD-TEF- hph For the skeleton, Ropyc Insertion into the Swa1 site resulted in the structure shown in Figure 1 The conditions used for target gene amplification are shown in Table 1.

[0042] Table 1

[0043] by Ropyc -F and Ropyc -R is primer, amplification Ropyc Fragments and primer sequences are shown in Table 7.

[0044] The PCR enzyme used for amplification was Phanta Max Super-Fidelity DNA Polymerase from Nanjing Novozymes Biotech Co., Ltd. The system is shown in Table 2.

[0045] Table 2

[0046] After amplification Ropyc The fragments were purified and recovered using agarose gel electrophoresis.

[0047] Plasmid 113-GPD-TEF-hph was digested with restriction endonuclease Swa I, and the linearized Swa I site integration plasmid was recovered from agarose gel.

[0048] One-step cloning was performed using ClonExpress MultiS One Step Cloning Kit from Nanjing Novogene Biotechnology Co., Ltd. The reaction system is shown in Table 3.

[0049] Table 3

[0050] The usage of linearized vector (x) and inserted fragment (y) can be calculated by the following formula: The optimal amount of fragment used (A) = [0.04 × number of base pairs of fragment] ng / Y ng / uL. (Y is the concentration) The optimal amount of carrier used (B) = [0.02 × number of base pairs of fragment] ng / X ng / uL. (X is the concentration) The circular recombinant vector was transformed into Escherichia coli DH5α competent cells, screened by hygromycin B resistance plate and verified by colony PCR and sequencing to obtain the positive recombinant plasmid 113-GPD-TEF- hph - Ropyc .

[0051] 2. Recombinant plasmid 113-GPD-TEF- hph - Ropyc - Romdh Construction Recombinant plasmid 113-GPD-TEF- hph - Ropyc - Romdh Based on 113-GPD-TEF- hph - Ropyc As the skeleton, the target gene Romdh Insert plasmid 113-GPD-TEF- hph - Ropyc The Sal 1 site was obtained, and the plasmid structure was as followsFigure 2 The target gene amplification conditions are shown in Table 4.

[0052] Table 4

[0053] The PCR enzyme used for amplification was Phanta Max Super-Fidelity DNA Polymerase from Nanjing Novozymes Biotech Co., Ltd. Romdh The fragments were purified and recovered by agarose gel electrophoresis. The primer sequences are shown in Table 7.

[0054] Plasmid 113-GPD-TEF- hph - Ropyc The restriction endonuclease used was Sal 1, and the linearized fragment was purified and recovered by agarose gel electrophoresis. The ClonExpress MultiS One Step Cloning Kit of Nanjing Novogene Biotechnology Co., Ltd. was used for one-step cloning. The linearized vector 113-GPD-TEF- hph - Ropyc and Romdh The fragments were connected, and the circular recombinant vector was transformed into Escherichia coli DH5α competent cells. The positive recombinant plasmid 113-GPD-TEF- hph - Ropyc - Romdh .

[0055] 3. Recombinant plasmid 113-GPD-TEF- hph - Ropyc - Romdh - Spmae 's construction.

[0056] Recombinant plasmid 113-GPD-TEF- hph - Ropyc - Romdh - Spmae Based on 113-GPD-TEF- hph - Ropyc - Romdh As the skeleton, the target gene Spmae Insert plasmid 113-GPD-TEF- hph - Ropyc - Romdh The Sal 1 site was obtained, and the plasmid structure was as follows Figure 3 The target gene amplification conditions are shown in Table 5.

[0057] Table 5

[0058] The PCR enzyme used for amplification was Phanta Max Super-Fidelity DNA Polymerase from Nanjing Novozymes Biotech Co., Ltd. Spmae The fragments were purified and recovered by agarose gel electrophoresis. The primer sequences are shown in Table 7.

[0059] Since plasmid 113-GPD-TEF- hph There are two gene-free expression cassettes, so Ropyc and Romdh It can be directly inserted into the two blank expression boxes of the plasmid. Spmae When inserting plasmid, construct plasmid 113-GPD-TEF- hph - Spmae To obtain its expression cassette pTEF- Spmae -tCYC1, and the expression cassette was combined with 113-GPD-TEF- hph - Ropyc - Romdh The three genes were connected to construct a recombinant plasmid for co-expression. The details are as follows: Plasmid 113-GPD-TEF- hph The restriction endonuclease used for enzyme digestion was Sal I, and the linearized Sal I site integration plasmid was recovered by agarose gel electrophoresis.

[0060] One-step cloning was performed using ClonExpress MultiS One Step Cloning Kit from Nanjing Novogene Biotechnology Co., Ltd. The linearized vector 113-GPD-TEF- hph and Spmae The fragments were connected, and the circular recombinant vector was transformed into Escherichia coli DH5α competent cells, screened by hygromycin B resistance plate and verified by colony PCR and sequencing to obtain the positive recombinant plasmid 113-GPD-TEF- hph - Spmae .

[0061] The PCR enzyme used for amplification was Phanta Max Super-Fidelity DNA Polymerase from Nanjing Novozymes Biotech Co., Ltd. Spmae The -tCYC1 fragment was purified and recovered by agarose gel electrophoresis. The primer sequences are shown in Table 7.

[0062] Plasmid 113-GPD-TEF- Ropyc - Romdh Inverse PCR was performed and the linearized plasmid was recovered by agarose gel electrophoresis.

[0063] One-step cloning was performed using ClonExpress MultiS One Step Cloning Kit from Nanjing Novogene Biotechnology Co., Ltd. The linearized vector 113-GPD-TEF- hph - Ropyc - Romdh With pTEF- Spmae -tCYC1 fragments were connected, and the circular recombinant vector was transformed into Escherichia coli DH5α competent cells, screened by hygromycin B resistance plate and verified by colony PCR and sequencing to obtain the positive recombinant plasmid 113-GPD-TEF- hph - Ropyc - Romdh - Spmae .

[0064] Table 6 Sequences inserted into each recombinant plasmid

[0065] Table 7 Primer sequences

[0066] Example 3 Construction of fusion protein plasmid 1. Recombinant plasmid 113-GPD-TEF- hph - Ropyc -Linker- Romdh Construction Recombinant plasmid 113-GPD-TEF- hph - Ropyc -Linker- Romdh Based on 113-GPD-TEF- hph As the skeleton, five different combinations of Ropyc -Linker 1-5 - Romdh Insert 113-GPD-TEF- hph Sal 1 site.

[0067] The sequences of Linker1-5 are: Linker1: GGGGGGGG; Linker2: EKGGGEK; Linker3: GGGEKGGG; Linker4: GGGSGGGS; Linker5: GGGGSGGPGS.

[0068] The conditions used for target gene amplification are shown in Table 8.

[0069] Table 8

[0070] The PCR enzyme used for amplification was Phanta Max Super-Fidelity DNA Polymerase from Nanjing Novozyme Biotechnology Co., Ltd. The fragment was purified and recovered by agarose gel electrophoresis. The primer sequences are shown in Table 11.

[0071] Plasmid 113-GPD-TEF- hph The restriction endonuclease used for enzyme digestion was Sal I, and the linearized Sal I site integration plasmid was recovered by agarose gel electrophoresis.

[0072] One-step cloning was performed using ClonExpress MultiS One Step Cloning Kit from Nanjing Novogene Biotechnology Co., Ltd. The linearized vector 113-GPD-TEF- hph The circular recombinant vector was connected with different combinations of linker fragments, and transformed into Escherichia coli DH5α competent cells. The positive recombinant plasmid 113-GPD-TEF- hph - Ropyc- Linker 1-5 - Romdh , plasmid structure see Figure 4 (Based on 113-GPD-TEF- hph - Ropyc -Linker4- Romdh For example.

[0073] 2. Recombinant plasmid 113-GPD-TEF- hph - Ropyc -Linker 1-5 - Romdh-Spmae Construction 113-GPD-TEF- hph - Ropyc -Linker 1-5 - Romdh For the skeleton, Spmae The fragment was inserted into its Swa 1 site to construct the recombinant plasmid 113-GPD-TEF- hph - Ropyc -Linker 1-5 - Romdh-Spmae The conditions used for target gene amplification are shown in Table 9.

[0074] Table 9

[0075] The PCR enzyme used for amplification was Phanta Max Super-Fidelity DNA Polymerase from Nanjing Novozymes Biotech Co., Ltd. Spmae The fragments were purified and recovered by agarose gel electrophoresis. The primer sequences are shown in Table 11.

[0076] Plasmid 113-GPD-TEF- hph - Ropyc -Linker 1-5 - Romdh The restriction endonuclease used for enzyme digestion was Sal I, and the linearized Sal I site integration plasmid was recovered by agarose gel electrophoresis.

[0077] One-step cloning was performed using ClonExpress MultiS One Step Cloning Kit from Nanjing Novogene Biotechnology Co., Ltd. The linearized vector 113-GPD-TEF- hph - Ropyc -Linker 1-5 - Romdh and Spmae The fragments were connected, and the circular recombinant vector was transformed into Escherichia coli DH5α competent cells. The positive recombinant plasmid 113-GPD-TEF- hph - Ropyc -Linker 1-5 - Romdh-Spmae , plasmid structure see Figure 5 (Based on 113-GPD-TEF- hph - Ropyc -Linker4- Romdh-Spmae for example).

[0078] Table 10 Insertion sequences in each recombinant plasmid

[0079] Table 11 Primer sequences

[0080] Example 4 Construction of recombinant bacteria 1. Recombinant bacteria R2 Construction will contain Ropyc - Romdh Gene expression cassette plasmid 113-GPD-TEF- hph - Ropyc - Romdh Pichia guilliermong gsh-slc-E-EA20 The recombinant bacteria were obtained R2.

[0081] The specific method is as follows: ① Pichia pastoris gsh-slc-E-EA20 Competent cells were prepared by culturing the strain overnight in YPD medium (containing 2% peptone, 1% yeast extract and 2% glucose).

[0082] ②Using the yeast transformation kit Zymo Research Corporation's Zymogen Frozen EZYeastTransformation Kit II, 113-GPD-TEF- hph - Ropyc - Romdh The gene was introduced into Pichia guilliermong competent cells for homologous recombination.

[0083] ③ Screening was performed using hygromycin screening medium. Single colonies grew out in 3-4 days. The positive clones identified by PCR were named recombinant bacteria R2. The screening medium contained: 20 g / L glucose, 10 g / L yeast powder, 20 g / L peptone, and 0.2 g / L hygromycin B.

[0084] 2. Recombinant bacteria R2-S , R-Linker 1-5 -R , R-Linker 1-5 -R-S Construction will contain Ropyc - Romdh - Spmae Gene expression cassette plasmid 113-GPD-TEF- hph - Ropyc - Romdh - Spmae 、113-GPD-TEF- hph - Ropyc -Linker 1-5 - Romdh 、113-GPD-TEF- hph - Ropyc -Linker 1-5 - Romdh - Spmae Pichia guilliermondii gsh-slc-E-EA20 The recombinant bacteria were obtained R2-S , R- Linker 1-5 -R , R-Linker 1-5 -R-S .

[0085] The specific method is the same as that of the recombinant strain R2 's construction.

[0086] Example 5 Application of recombinant bacteria in the production of malic acid 1. Cultivation of engineered bacteria Respectively use the recombinant Pichia quaternaria in Example 3 R2 , R2-S , R-Linker 1-5 -R , R-Linker 1-5 -R- S The specific method is as follows: take out the strain from the seed tube, inoculate it into a YPD test tube with a 1% inoculation amount, and culture it at 30°C for 24 hours to obtain the seed solution; inoculate the seed solution into 50 mL of fermentation medium with a 1% inoculation amount, and culture it at 30°C and 220 rpm for 7 days.

[0087] Seed culture medium (YPD medium / test tube): 10 g / L yeast powder, 20 g / L peptone, 20 g / L glucose.

[0088] Synthetic fermentation medium (shake flask): 100 x salt (salt solution): 10 mL / L; trace element Trace: 1 mL / L; Tris ethanesulfonic acid: 2.292 g / L; YNB 0.5 g / L; Na2HPO4 20 g / L; trisodium citrate 10 g / L; L-phenylalanine 8 g / L; glucose 40 g / L (digestion).

[0089] Synthetic fermentation medium (fermenter): 100 x salt (salt solution): 10 mL / L; trace element Trace: 1 mL / L; Tris ethanesulfonic acid: 2.292 g / L; YNB 0.5 g / L; Na2HPO4 20 g / L; trisodium citrate 10 g / L; L-phenylalanine 10 g / L; glucose mother solution 600 g / L (digestion).

[0090] 100 x salt (salt solution): NaCl 100 g / L; MgCl2·6H2O 50 g / L; KH2PO4 20 g / L; NH4Cl30 g / L; KCl 30 g / L; CaCl2·2H2O 1.5 g / L.

[0091] Trace elements Trace: HCl 25% solution, w / w) 10 mL / L; FeCl2·4H2O 1.5 g / L; CoCl2·6H2O 0.19 g / L; MnCl2·4H2O 0.1 g / L; ZnCl2 0.07 g / L; H3BO3 0.006 g / L; Na2MoO4·2H2O 0.036 g / L; NiCl2·6H2O 0.024 g / L; CuCl2·2H2O 0.002 g / L.

[0092] Determination of organic acid content: High performance liquid chromatography (HPLC) was used. The fermentation broth was centrifuged at 12000 r / min for 120s, and the supernatant was taken. The supernatant was diluted to an appropriate multiple and filtered with a 0.22 μm water filter membrane. The sample was placed in a liquid sample bottle and then placed in a liquid chromatography instrument for detection. The instrument model was the American Dionex Ultimate 3000 series; the sugar column model used was BIO-RAD, Aminx, HPX-87H, USA; the main component of the mobile phase was 0.2 g / L sulfuric acid, the column temperature was controlled at 55°C, the detection wavelength of the UV detector was 215 nm, the flow rate was 0.5 mL / min, and the injection volume was 10 μL.

[0093] Figure 6 The yield of malic acid produced by the starting strain and different recombinant bacteria. R2 , R2-S , R-Linker 1 - R , R-Linker 2 -R , R-Linker 3 -R , R-Linker 4 -R , R-Linker 5 -R , R-Linker 1 -R-S , R-Linker 2 -R-S , R-Linker 3 -R-S , R-Linker 4 -R-S , R-Linker 5 -R-SThe malic acid yields were 5.16 g / L, 6.42 g / L, 6.85 g / L, 4.8 g / L, 6.32 g / L, 8.39 g / L, 6.72 g / L, 7.22 g / L, 5.55 g / L, 8.19 g / L, 10.78 g / L and 8.68 g / L, respectively.

[0094] 2. Temperature Optimization of Recombinant Bacteria R-Linker 4 -R-S Production of malic acid The recombinant bacteria with the highest yield R-Linker 4 -R-S Fermentation was carried out at different fermentation temperatures, namely 18℃, 25℃, 30℃, 33℃ and 37℃. The yields of malic acid were 7.64 g / L, 8.56 g / L, 10.78 g / L, 12.32 g / L, 8.19 g / L ( Figure 7 The highest malic acid yield was obtained at 33°C, so 33°C was used as the subsequent fermentation temperature.

[0095] Example 6 5L Fermenter Batch Fermentation Seed liquid culture: a. Primary seed solution: Take the recombinant strain from the cryopreservation tube at a 1% inoculation rate R-Linker4-R-S The bacterial solution was inoculated into a YPD test tube and cultured at 30°C, 200 r for 24 h as the primary seed solution; b. Secondary seed solution: Take the primary seed solution and inoculate it into a new seed culture medium at a 10% inoculation rate. Culture it at a constant temperature under the same conditions as in step a to obtain the seed solution for fermentation.

[0096] ② Fed-batch fermentation The seed solution obtained from the seed culture was inoculated into a 5 L fermentation tank filled with fermentation medium, and the recombinant strain R- Linker4-R-S Batch fermentation was carried out in a 5 L fermenter at a temperature of 33°C without adding any pH regulator. The initial glucose concentration in the fermenter was 30-40 g / L (actually detected in this embodiment was about 34.2 g / L). Glucose was added every day from the second day of fermentation to a concentration of 30 g / L. After seven days of cultivation, the cell dry weight was measured and the malic acid content in the fermentation broth was measured ( Figure 8 ). Through batch fermentation, the yield of malic acid reached 72.56 g / L, which was higher than that of the original strain. gsh - slc -E-EA20 output increased by 66.81 times.

[0097] This patent introduces the malic acid synthesis pathway to construct a strain of Pichia quaternaria that can synthesize and accumulate malic acid from scratch, and then Ropyc and Romdh Fusion expression was performed to further increase the yield of malic acid. Finally, through batch fermentation in a 5 L fermenter, the yield of malic acid reached 72.56 g / L, and in a larger volume fermenter, the yield of malic acid is expected to be further increased, laying the foundation for subsequent industrial fermentation.

Claims

1. A recombinant strain of Pichia guilliermongosaccharomyces producing malic acid, characterized in that: The recombinant bacteria express the pyruvate carboxylase gene from Rhizopus oryzae in the host bacteria. Ropyc , malate dehydrogenase gene Romdh and / or a malate transporter gene from Schizosaccharomyces pombe Spmae get; Wherein, the host bacteria is a genetically modified strain of Pichia guilliermongo gsh-slc-E-EA20 .

2. The recombinant bacterium according to claim 1, characterized in that Said Ropyc Gene, Romdh Genes are fused and expressed by inserting linkers.

3. The recombinant bacterium according to claim 2, characterized in that The amino acid sequence of the linker is GGGGGGGG, GGGEKGGG, GGGSGGGS or GGGGSGGPGS, preferably GGGSGGGS.

4. The recombinant bacterium according to claim 1, characterized in that Said Ropyc , Romdh and Spmae The nucleotide sequences are shown in SEQ ID NOs: 1-3, respectively.

5. The method for constructing the recombinant bacterium according to any one of claims 1 to 4, characterized in that: include: Build Ropyc , Romdh and / or Spmae The co-expression plasmid is linearized and then introduced into a host bacterium through a yeast transformation kit to obtain the recombinant bacterium.

6. The construction method according to claim 5, characterized in that: Used to express Ropyc , Romdh and Spmae The vector plasmid of the gene is 113-GPD-TEF plasmid.

7. Use of the recombinant bacteria according to any one of claims 1 to 4 in fermentation production of malic acid.

8. The use according to claim 7, characterized in that: The recombinant bacteria are subjected to seed culture and fermentation culture to synthesize malic acid.

9. The use according to claim 7, characterized in that: The fermentation temperature of the recombinant bacteria is 18-37°C, preferably 30-33°C.

10. The use according to claim 7, characterized in that: The culture medium for the fermentation culture of the recombinant bacteria does not contain a neutralizer.